Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Adults - 18 - 64
  • Massachusetts
  • Fall River


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com




Results

Post your clinical trial on JoinClinicalTrials.com
Hot

Post your clinical trial on JoinClinicalTrials.com


Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

Results 1 - 1 of 1
  • <<
  • <
  • 1
  • >
  • >>

  • Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder
    NCT04059549
    Conditions:   Alcohol Use Disorder;   Couples;   Behavior, Addictive
    Interventions:   Behavioral: PartnerCHESS;   Behavioral: A-CHESS
    Sponsors:   University of Wisconsin, Madison;   University of Massachusetts, Worcester;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting
  • Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
    NCT03698669
    Condition:   Opioid-Related Disorders
    Interventions:   Behavioral: Treating Opioid Patients' Pain and Sadness (TOPPS);   Behavioral: Health Education (HE)
    Sponsors:   Boston University;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)
    NCT04141982
    Condition:   Tuberculosis
    Intervention:   Diagnostic Test: T-Cell SelectTM Kit
    Sponsor:   Oxford Immunotec
    Recruiting
  • Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
    NCT03951077
    Condition:   Polycystic Ovary Syndrome
    Interventions:   Drug: Elagolix;   Drug: Placebo
    Sponsor:   AbbVie
    Recruiting
  • A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
    NCT03886220
    Condition:   Uterine Fibroids
    Interventions:   Drug: Elagolix;   Drug: Placebo
    Sponsor:   AbbVie
    Recruiting
  • AMPLATZER PFO Occluder Post Approval Study
    NCT03309332
    Conditions:   Stroke;   Patent Foramen Ovale
    Intervention:   Device: AMPLATZER™ PFO Occluder
    Sponsor:   Abbott Medical Devices
    Recruiting
  • A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease
    NCT03677648
    Condition:   Crohn's Disease
    Interventions:   Drug: SHR0302;   Drug: Placebos
    Sponsor:   Reistone Biopharma Company Limited
    Recruiting
  • A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
    NCT03675477
    Condition:   Ulcerative Colitis
    Interventions:   Drug: SHR0302;   Drug: Placebos
    Sponsor:   Reistone Biopharma Company Limited
    Recruiting
  • A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
    NCT04184622
    Conditions:   Overweight;   Obesity
    Interventions:   Drug: Tirzepatide;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting
  • A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
    NCT03987919
    Condition:   Type 2 Diabetes
    Interventions:   Drug: Tirzepatide;   Drug: Semaglutide
    Sponsor:   Eli Lilly and Company
    Recruiting
  • Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
    NCT03937479
    Condition:   COPD
    Interventions:   Drug: Ensifentrine (formerly RPL554) 0.375 mg twice daily plus placebo, in addition to tiotropium;   Drug: Ensifentrine (formerly RPL554) 0.75 mg twice daily plus placebo, in addition to tiotropium;   Drug: Ensifentrine (formerly RPL554) 1.5 mg twice daily plus placebo, in addition to tiotropium;   Drug: Ensifentrine (formerly RPL554) 3.0 mg twice daily plus placebo, in addition to tiotropium;   Drug: Ensifentrine (formerly RPL554) placebo twice daily, in addition to tiotropium
    Sponsors:   Verona Pharma plc;   Iqvia Pty Ltd;   LGC Limited
    Recruiting
  • A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
    NCT03931785
    Condition:   Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Interventions:   Drug: MD-7246;   Drug: Placebo
    Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC
    Recruiting
  • A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
    NCT03915964
    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Baricitinib;   Drug: TNF Inhibitor
    Sponsors:   Eli Lilly and Company;   Incyte Corporation
    Recruiting
  • Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis
    NCT03890120
    Condition:   Primary Sclerosing Cholangitis
    Interventions:   Drug: Cilofexor;   Drug: Placebo
    Sponsor:   Gilead Sciences
    Recruiting
  • A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
    NCT03730662
    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Tirzepatide;   Drug: Insulin Glargine
    Sponsor:   Eli Lilly and Company
    Recruiting
  • Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
    NCT03569007
    Condition:   Celiac Disease
    Interventions:   Drug: Larazotide;   Drug: Matching Placebo
    Sponsor:   Innovate Biopharmaceuticals
    Recruiting
  • A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
    NCT03524092
    Condition:   Ulcerative Colitis
    Interventions:   Drug: Mirikizumab;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting
  • An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
    NCT03518086
    Condition:   Ulcerative Colitis
    Interventions:   Drug: Mirikizumab;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting
  • A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men
    NCT03518034
    Conditions:   Hypogonadism;   Cardiovascular Diseases
    Interventions:   Drug: Testosterone;   Drug: Placebo
    Sponsors:   AbbVie;   Acerus Pharmaceuticals Corporation;   Allergan Sales, LLC;   Endo Pharmaceuticals;   Upsher-Smith Laboratories
    Recruiting
  • QP ExCELs: MultiPole Pacing (MPP) Sub-Study
    NCT03155724
    Condition:   Heart Failure
    Intervention:   Device: MultiPole Pacing
    Sponsor:   Biotronik, Inc.
    Recruiting
  • Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
    NCT02923726
    Condition:   Sudden Cardiac Death
    Interventions:   Device: Arm 1 (ATP+Shock);   Device: Arm 2 (shock only)
    Sponsors:   Boston Scientific Corporation;   ICON plc
    Recruiting
  • Triple Combination Therapy in High Risk Crohn's Disease (CD)
    NCT02764762
    Condition:   Crohn Disease
    Interventions:   Drug: Vedolizumab;   Drug: Adalimumab;   Drug: Methotrexate
    Sponsor:   Takeda
    Recruiting
  • Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
    NCT02290028
    Condition:   Heart Failure
    Intervention:   Device: Sentus QP left ventricular lead
    Sponsors:   Biotronik SE & Co. KG;   Biotronik, Inc.
    Recruiting
  • Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
    NCT01872975
    Conditions:   Stage IB Breast Cancer;   Stage II Breast Cancer
    Interventions:   Radiation: regional nodal XRT;   Radiation: chestwall XRT;   Radiation: WBI
    Sponsors:   NSABP Foundation Inc;   National Cancer Institute (NCI);   Radiation Therapy Oncology Group
    Recruiting
  • An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
    NCT03950232
    Condition:   Ulcerative Colitis
    Intervention:   Drug: Etrasimod
    Sponsor:   Arena Pharmaceuticals
    Recruiting
  • Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
    NCT03945188
    Condition:   Ulcerative Colitis
    Interventions:   Drug: Etrasimod;   Drug: Placebo
    Sponsor:   Arena Pharmaceuticals
    Recruiting
  • Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)
    NCT03893448
    Conditions:   Pneumococcal Infections;   Pneumococcal Vaccines
    Interventions:   Biological: V114;   Biological: Prevnar 13™;   Biological: RotaTeq™;   Biological: Pentacel™;   Biological: RECOMBIVAX HB™;   Biological: VAQTA™;   Biological: M-M-R™;   Biological: VARIVAX™;   Biological: HIBERIX™
    Sponsor:   Merck Sharp & Dohme Corp.
    Recruiting
  • A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma
    NCT03769090
    Condition:   Asthma
    Interventions:   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg;   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg;   Combination Product: Albuterol sulfate metered-dose inhaler 180 μg
    Sponsor:   Bond Avillion 2 Development LP
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC